The increasing role for structured and personalized self-monitoring of blood glucose (SMBG) in management of type 2 diabetes has been underlined by randomized and prospective clinical trials. These include Structured Testing Program (or STeP), St. Carlos, Role of Self-Monitoring of Blood Glucose and Intensive Education in Patients with Type 2 Diabetes Not Receiving Insulin, and Retrolective Study Self-Monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (or ROSSO)-in-praxi follow-up. The evidence for the benefit of SMBG both in insulin-treated and non-insulin-treated patients with diabetes is also supported by published reviews, meta-analyses, and guidelines. A Cochrane review reported an overall effect of SMBG on glycemic control up to 6 months after initiation, which was considered to subside after 12 months. Particularly, the 12-month analysis has been criticized for the inclusion of a small number of studies and the conclusions drawn. The aim of this article is to review key publications on SMBG and also to put them into perspective with regard to results of the Cochrane review and current aspects of diabetes management.
ParkinCGHinnenDATetrickDL, Effective use of structured self-management of blood glucose in type 2 diabetes: Lessons from the STeP study. Clin Diabetes.2011;29 (4): 131–8.
2.
AbrairaCColwellJANuttallFQSawinCTNagelNJComstockJPEmanueleNVLevinSRHendersonWLeeHS, Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care.1995;18 (8): 1113–23.
3.
RydénLStandlEBartnikMVan den BergheGBetteridgeJde BoerMJCosentinoFJönssonBLaaksoMMalmbergKPrioriSOstergrenJTuomilehtoJThrainsdottirIVanhorebeekIStramba-BadialeMLindgrenPQiaoQPrioriSGBlancJJBudajACammJDeanVDeckersJDicksteinKLekakisJMcGregorKMetraMMoraisJOsterspeyATamargoJZamoranoJLDeckersJWBertrandMCharbonnelBErdmannEFerranniniEFlyvbjergAGohlkeHJuanateyJRGrahamIMonteiroPFParhoferKPyöräläKRazISchernthanerGVolpeMWoodD; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J.2007;28 (1): 88–136.
4.
AllemannSHourietCDiemPStettlerC.Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: A systematic review and meta-analysis. Curr Med Res Opin.2009;25 (12): 2903–13.
5.
KovatchevBPOttoECoxDGonder-FrederickLClarkeW.Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care.2006;29 (11): 2433–8.
6.
SchnellOAlawiHBattelinoTCerielloADiemPFeltonAGrzeszczakWHarnoKKemplerPSatmanIVergèsB.Consensus statement on self-monitoring of blood glucose in diabetes: A European perspective. Diab Metab Heart.2009;18 (4): 285–9.
7.
PeelEParryODouglasMLawtonJ.Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: A qualitative study of patients' perspectives. Br J Gen Pract.2004;54 (500): 183–8.
8.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet.1998;352 (9131): 837–53.
9.
PolonskyWHFisherLSchikmanCHHinnenDAParkinCGJelsovskyZPetersenBSchweitzerMWagnerRS, Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: Results from the Structured Testing Program study. Diabetes Care.2011;34 (2): 262–7.
10.
PolonskyWHFisherLSchikmanCHHinnenDAParkinCGJelsovskyZAxel-SchweitzerMPetersenBWagnerRS, A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: Results from the STeP study. Diabetes Technol Ther.2011;13 (8): 797–802.
11.
MartinSSchneiderBHeinemannLLodwigVKurthHJKolbHScherbaumWA, Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: An epidemiological cohort study. Diabetologia.2006;49 (2): 271–8.
12.
KhamsehMEAnsariMMalekMShafieeGBaradaranH.Effects of a structured self-monitoring of blood glucose method on patient self-management behavior and metabolic outcomes in type 2 diabetes mellitus. J Diabetes Sci Technol.2011;5 (2): 388–93.
13.
KempfKKruseJMartinS.ROSSO-in-praxi: A self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther.2010;12 (7): 547–53.
14.
KarterAJParkerMMMoffetHHSpenceMMChanJEttnerSLSelbyJV, Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care.2006;29 (8): 1757–63.
15.
FranciosiMLucisanoGPellegriniFCantarelloAConsoliACuccoLGhidelliRSartoreGSciangulaLNicolucciA; ROSES Study Group. ROSES: Role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med.2011;28 (7): 789–96.
16.
FisherLPolonskyWHParkinCGJelsovskyZPetersenBWagnerRS, The impact of structured blood glucose testing on attitudes toward self-management among poorly controlled, insulin-naive patients with type 2 diabetes. Diabetes Res Clin Pract.2012;96 (2): 149–55.
17.
FarmerAWadeAGoyderEYudkinPFrenchDCravenAHolmanRKinmonthALNeilA.Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: Open parallel group randomised trial. BMJ.2007;335 (7611): 132.
18.
DuránAMartínPRunkleIPérezNAbadRFernándezMDel ValleLSanzMFCalle-PascualAL, Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes.2010;2 (3): 203–11.
19.
ShiraiwaTTakaharaMKanetoHMiyatsukaTYamamotoKYoshiuchiKSakamotoKMatsuokaTAMatsuhisaMYamasakiYShimomuraI.Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy. Diabetes Res Clin Pract.2010;90 (3): e91–2.
20.
CavalotFPagliarinoAValleMDi MartinoLBonomoKMassuccoPAnfossiGTrovatiM.Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: Lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care.2011;34 (10): 2237–43.
21.
RizzoMRMarfellaRBarbieriMBoccardiVVestiniFLettieriBCanonicoSPaolissoG.Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care.2010;33 (10): 2169–74.
22.
BuscemiSReABatsisJAArnoneMMattinaACerasolaGVergaS.Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in type 2 diabetes. Diabet Med.2010;27 (8): 872–8.
23.
BrownleeMHirschIB, Glycemic variability: A hemoglobin A1c-independent risk factor for diabetic complications. JAMA.2006;295 (14): 1707–8.
24.
NalysnykLHernandez-MedinaMKrishnarajahG.Glycaemic variability and complications in patients with diabetes mellitus: Evidence from a systematic review of the literature. Diabetes Obes Metab.2010;12 (4): 288–98.
25.
MonnierLMasEGinetCMichelFVillonLCristolJPColetteC.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA.2006;295 (14): 1681–7.
26.
KohnertKDAugsteinPHeinkePZanderEPetersonKFreyseEJSalzsiederE.Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract.2007;77 (3): 420–6.
27.
WelschenLMBloemendalENijpelsGDekkerJMHeineRJStalmanWABouterLM, Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev.2005; (2): CD005060.
28.
HirschIBBodeBWChildsBPCloseKLFisherWAGavinJRGinsbergBHRaineCHVerdereseCA, Self-monitoring of blood glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: Consensus recommendations for improving SMBG accuracy, utilization, and research. Diabetes Technol Ther.2008;10 (6): 419–39.
29.
TengbladAGrodzinskyELindstromKMolstadSBorgquistLOstgrenCJ, Self-monitoring of blood glucose and glycaemic control in type 2 diabetes. Scand J Prim Health Care.2007;25 (3): 140–6.
30.
SimonJGrayAClarkePWadeANeilAFarmerA; Diabetes Glycaemic Education and Monitoring Trial Group. Cost effectiveness of self-monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: Economic evaluation of data from the DiGEM trial. BMJ.2008;336 (7654): 1177–80.
31.
MalandaULWelschenLMRiphagenIIDekkerJMNijpelsGBotSD, Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev.2012;1: CD005060.
32.
SchnellOAlawiHBattelinoTCerielloADiemPFeltonAGrzeszczakWHarnoKHummelMKemplerPSatmanIVergèsB.Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin: Letter to the editor. Cochrane Database Syst Rev.2012;1: CD005060.
33.
FontbonneABillaultBAcostaMPercheronCVarennePBesseAEschwegeEMonnierLSlamaGPassaP.Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab.1989;15 (5): 255–60.
34.
GuerciBDrouinPGrangéVBougnèresPFontainePKerlanVPassaPThivoletCHVialettesBCharbonnelB; ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab.2003;29 (6): 587–94.
35.
DavidsonMBCastellanosMKainDDuranP.The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: A blinded, randomized trial. Am J Med.2005;118 (4): 422–5.
36.
StrattonIMAdlerAINeilHAMatthewsDRManleySECullCAHaddenDTurnerRCHolmanRR, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ.2000;321 (7258): 405–12.
37.
KleefstraNHortensiusJLogtenbergSJSlingerlandRJGroenierKHHouwelingSTGansROvan BallegooieEBiloHJ, Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC). Neth J Med.2010;68 (1): 311–6.
38.
FarmerAWadeAFrenchDPGoyderEKinmonthALNeilA.The DiGEM trial protocol–a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]. BMC Fam Pract.2005;6: 25.
39.
SchnellOHeinemannL.Self-monitoring of blood glucose in noninsulin-treated patients with type 2 diabetes: A never ending story?J Diabetes Sci Technol.2007;1 (5): 614–6.
40.
SchnellOAlawiHBattelinoTCerielloADiemPFeltonAGrzeszczakWHarnoKKemplerPSatmanIVergèsB.Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: A European perspective and expert recommendation. Diabetes Technol Ther.2011;13 (9): 959–65.
41.
StephensJWCarmanJEBrooksCJLyonsRAFordDVPriceDEBainSC, Comment on: Polonsky et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: Results from the structured testing program study. Diabetes Care2011;34: 262–267. Diabetes Care. 2011;34 (5): e57; author reply e58.
42.
FarmerAJPereraRWardAHeneghanCOkeJBarnettAHDavidsonMBGuerciBCoatesVSchwedesUO'MalleyS.Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ.2012;344: e486.
43.
KlonoffDCBlondeLCembrowskiGChacraARCharpentierGColagiuriSDaileyGGabbayRAHeinemannLKerrDNicolucciAPolonskyWSchnellOVigerskyRYaleJF; Coalition for Clinical Research-Self-Monitoring of Blood Glucose Scientific Board. Consensus report: The current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol.2011;5 (6): 1529–48.
44.
KempfKKruseJMartinS.ROSSO-in-praxi follow-up: Long-term effects of self-monitoring of blood glucose on weight, hemoglobin a1c, and quality of life in patients with type 2 diabetes mellitus. Diabetes Technol Ther.2012;14 (1): 59–64.
45.
RadloffLS, The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Measure.1977;1: 385–401.
46.
BrazierJEHarperRJonesNMO'CathainAThomasKJUsherwoodTWestlakeL.Validating the SF-36 health survey questionnaire: New outcome measure for primary care. BMJ.1992;305 (6846): 160–4.
47.
RodbardHWSchnellOUngerJReesCAmstutzLParkinCGJelsovskyZWegmannNAxel-SchweitzerMWagnerRS, Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data. Diabetes Care. Apr2012;35 (4): 693–8.
48.
ScaviniMBosiECerielloAGiorginoFPortaMTiengoAVespasianiGBottalicoDMarinoRParkinCBonizzoniECucinottaD.Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): A study to determine the effect of a structured SMBG intervention. Acta Diabetol.2011. Epub ahead of print.
49.
ClarCBarnardKCumminsERoylePWaughN; Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: Systematic review. Health Technol Assess.2010;14 (12): 1–140.
50.
SchnellOAlawiHBattelinoTCerielloADiemRFeltonAGrzeszczakWHämoKKemplerPSatmanIVergesB.A consensus of clinical cases on self-monitoring of blood glucose: A European perspective. Diab Metab Heart.2010;19 (5): 3–25.
51.
CerielloAGalloMArmentanoVPerrielloGGentileSDe MicheliA; Associazione Medici Diabetologi. Personalizing treatment in type 2 diabetes: A self-monitoring of blood glucose inclusive innovative approach. Diabetes Technol Ther.2012;14 (4): 373–8.
52.
Action to Control Cardiovascular Risk in Diabetes Study Group, GersteinHCMillerMEByingtonR PGoffDCJrBiggerJTBuseJBCushmanWCGenuthSIsmail-BeigiFGrimmRHJrProbstfieldJLSimons-MortonDGFriedewaldWT, Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med.2008;358 (24): 2545–59.
53.
ADVANCE Collaborative Group, PatelAMacMahonSChalmersJNealBBillotLWoodwardMMarreMCooperMGlasziouPGrobbeeDHametPHarrapSHellerSLiuLManciaGMogensenCEPanCPoulterNRodgersAWilliamsBBompointSde GalanBEJoshiRTravertF.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med.2008;358 (24): 2560–72.
54.
DuckworthWAbrairaCMoritzTRedaDEmanueleNReavenPDZieveFJMarksJDavisSNHaywardRWarrenSRGoldmanSMcCarrenMVitekMEHendersonWGHuangGD; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med.2009;360 (2): 129–39.
55.
Del PratoS. Megatrials in type 2 diabetes. From excitement to frustration?Diabetologia.2009;52 (7): 1219–26.
56.
Working Group on Personalised Therapy in Type 2 Diabetes; Italian Association of Medical Diabetologists. Personalization of therapy in type 2 diabetes. http://www.aemmedi.it/algoritmi/intro-inglese.html.
57.
KlonoffDCBergenstalRBlondeLBorenSAChurchTSGaffaneyJJovanovicLKendallDMKollmanCKovatchevBPLeippertCOwensDRPolonskyWHReachGRenardERiddellMCRubinRRSchnellOSiminieroLMVigerskyRAWilsonDMWollitzerAO, Consensus report of the Coalition For Clinical Research-Self-Monitoring of Blood Glucose. J Diabetes Sci Technol.2008;2 (6): 1030–53.
